We used PB ILCs as a model to unravel how the antigen-presenting capacity of human ILCs is regulated by CRC-associated cytokines, i.e., IL-1β, IL-18, IFN-γ, and TGF-β51,52. This evidence concerns the gene IL1B and colorectal carcinoma.